336 related articles for article (PubMed ID: 17903684)
1. Left-ventricular hypertrophy and coronary artery disease.
Pierdomenico SD
Am J Hypertens; 2007 Oct; 20(10):1036-7. PubMed ID: 17903684
[No Abstract] [Full Text] [Related]
2. Hypertensive heart disease--significance of left ventricular hypertrophy.
Schmieder RE
J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S50-5. PubMed ID: 1283190
[TBL] [Abstract][Full Text] [Related]
3. Effect of changes in blood pressure and left ventricular mass induced by antihypertensive treatment on ventricular arrhythmias in essential hypertension.
Muiesan ML; Zulli R; Rizzoni D; Calebich S; Malerba M; Porteri E; Agabiti-Rosei E
J Hypertens Suppl; 1993 Dec; 11(5):S104-5. PubMed ID: 8158296
[No Abstract] [Full Text] [Related]
4. Hypertension and cardiac arrhythmias: a review of the epidemiology, pathophysiology and clinical implications.
Yiu KH; Tse HF
J Hum Hypertens; 2008 Jun; 22(6):380-8. PubMed ID: 18337759
[TBL] [Abstract][Full Text] [Related]
5. [Arterial hypertension and cardiac arrhythmias].
Vester EG
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
[TBL] [Abstract][Full Text] [Related]
6. [Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor].
Schmieder RE; Messerli FH
Schweiz Med Wochenschr; 1993 Jan; 123(4):99-107. PubMed ID: 7678943
[TBL] [Abstract][Full Text] [Related]
7. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
8. Management of hypertension in patients with cardiac disease: use of renin-angiotensin blocking agents.
Prisant LM
Am J Med; 2008 Aug; 121(8 Suppl):S8-15. PubMed ID: 18638617
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting enzyme inhibition for cardiac hypertrophy in patients with end-stage renal disease: what is the evidence?
Wang AY; Li PK; Lui SF; Sanderson JE
Nephrology (Carlton); 2004 Aug; 9(4):190-7. PubMed ID: 15363049
[TBL] [Abstract][Full Text] [Related]
10. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
11. [Left ventricular hypertrophy regression in arterial hypertension. The efficacy of the angiotensin II type 1 receptor antagonists].
González-Juanatey JR; Vallés Belsué F
Med Clin (Barc); 2000; 114 Suppl 1():39-42. PubMed ID: 10812574
[No Abstract] [Full Text] [Related]
12. Effects of blood pressure reduction with trandolapril and enalapril on left ventricular hypertrophy and exercise tolerance.
Leonetti G; Fogari R; Mazzola C; Pasotti C; Ponti GB; Marelli C; Zanchetti A
J Hypertens Suppl; 1993 Dec; 11(5):S356-7. PubMed ID: 8158420
[No Abstract] [Full Text] [Related]
13. Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuum.
Chrysant SG
Clin Ther; 2008; 30 Pt 2():2181-90. PubMed ID: 19281913
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular hypertrophy in hypertension: etiology, treatment, and controversies.
Phillips RA; Diamond JA; Gharavi A
Mt Sinai J Med; 1998 Mar; 65(2):97-103. PubMed ID: 9520512
[No Abstract] [Full Text] [Related]
15. Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation.
Jennings DL; Taber DJ
Ann Pharmacother; 2008 Jan; 42(1):116-20. PubMed ID: 18094340
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of renin-angiotensin blockade in patients receiving dialysis.
Suzuki H
Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):397-405. PubMed ID: 19491138
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin receptor blockers: novel role in high-risk patients.
Javed U; Deedwania PC
Cardiol Clin; 2008 Nov; 26(4):507-26. PubMed ID: 18929228
[TBL] [Abstract][Full Text] [Related]
18. The primary benefits of angiotensin-converting enzyme inhibition on cardiac remodeling occur during sleep time in murine pressure overload hypertrophy.
Martino TA; Tata N; Simpson JA; Vanderlaan R; Dawood F; Kabir MG; Khaper N; Cifelli C; Podobed P; Liu PP; Husain M; Heximer S; Backx PH; Sole MJ
J Am Coll Cardiol; 2011 May; 57(20):2020-8. PubMed ID: 21565639
[TBL] [Abstract][Full Text] [Related]
19. Management of hypertension in patients with chronic kidney disease and diabetes mellitus.
Palmer BF
Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation.
Plante E; Lachance D; Beaudoin J; Champetier S; Roussel E; Arsenault M; Couet J
Circ Heart Fail; 2009 Jan; 2(1):25-32. PubMed ID: 19808312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
